This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the...

Key Features:A great team of contributors who are specialists from all the critical branches or fields in biopharmacy, such as BioPharma Business Development; Centre for Health Management; Bioengineering; School of Medicine; and Intellectual Property Institute.